Vis enkel innførsel

dc.contributor.authorNugusse, Teka
dc.contributor.authorLemlem, Semarya Berhe
dc.contributor.authorDeressa, Jembere
dc.contributor.authorKisa, Sezer
dc.coverage.spatialEthiopia, Addis Ababaen_US
dc.date.accessioned2021-06-17T11:52:58Z
dc.date.available2021-06-17T11:52:58Z
dc.date.created2021-02-24T22:57:36Z
dc.date.issued2021-02-24
dc.identifier.citationCancer Management and Research. 2021, 13, (1909-1916).en_US
dc.identifier.issn1179-1322
dc.identifier.urihttps://hdl.handle.net/11250/2759972
dc.description.abstractBackground: Fatigue is a subjective and distressing symptom in cancer patients and has profound effects on daily life. The rates of fatigue during treatment are reported to be 25– 90%. Its causes are secondary to their treatment course, cancer itself and associated factors. Purpose: To assess the prevalence of fatigue and associated factors among cancer patients at Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia, 2019. Patients and Methods: A cross-sectional study design was conducted on cancer patients undergoing treatment in Tikur Anbessa Specialized Hospital. A sample of 278 was selected using systematic random sampling technique and Brief Fatigue Inventory questionnaire was used for data collection. The data were entered into EPI data version 3.1 and transferred to SPSS version 24 for analysis. Bivariate and multivariable logistic regression were conducted to summarize the data. The significant statistical test was determined at 95% confidence interval and at p< 0.05. Results: The mean age of the participants was 44.9 ± 14 years. The prevalence of fatigue identified by this study was 208 (74.8%). Age, stage of cancer, presence of infection, type of cancer, and type of treatment had shown a significant association with fatigue [AOR = 3.15, 95% CI: (1.35– 7.34)], [AOR = 0.02, 95% CI: (0.003– 0.172)], [AOR = 4.15, 95% CI: (1.06– 16.07)], [AOR = 5.19, 95% CI: (1.59– 16.90)], [AOR = 0.18, 95% CI: (0.07– 0.462)] respectively. Conclusion: The prevalence of fatigue in cancer patients in this study was high. Risk factors were age of the patients, stage of cancer, presence of infection, cervical cancer and radiation therapy.en_US
dc.language.isoengen_US
dc.publisherDove Medical Pressen_US
dc.relation.ispartofseriesCancer Management and Research;volume 13
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.subjectCanceren_US
dc.subjectFatiguesen_US
dc.subjectChemotherapyen_US
dc.subjectSpecialized hospitalsen_US
dc.subjectEthiopiaen_US
dc.titlePrevalence of Fatigue and Associated Factors Among Cancer Patients Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopiaen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 Nugusse et al.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
dc.identifier.doihttps://doi.org/10.2147/CMAR.S291298
dc.identifier.cristin1893456
dc.source.journalCancer Management and Researchen_US
dc.source.volume13en_US
dc.source.pagenumber1909-1916en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal